ReginaR.BerkovichMDPhD

PubMed

• 2 citations
  Comparative pharmacokinetics and bioavailability of monomethyl fumarate following a single oral dose of Bafiertam® (monomethyl fumarate) versus Vumerity® (diroximel fu...
  Franck S Rousseau, Laurene Wang, Tiffany N Sprague, Thomas W Lategan, Regina R Berkovich
  Multiple Sclerosis and Related Disorders. 2023-02-01
• 6 citations
  Characterizing the 'feel-good experience' in multiple sclerosis patients treated with natalizumab or other therapies.
  John Foley, Regina Berkovich, Mark Gudesblatt, Elizabeth Luce, Beth Schneider
  Neurodegenerative Disease Management. 2023-02-01
• 26 citations
  Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223
  Brian Steingo, Yaser Al Malik, Ann D Bass, Regina Berkovich, Matthew Carraro
  Journal of Neurology. 2020-06-24

Journal Articles

• Intravenous Dextromethorphan/Quinidine Inhibits Activity of Dura-sensitive Spinal Trigeminal Neurons in Rats  
  Berkovich R., Sokolov A., Lyubashina O, European Journal of Pain, 1/1/2014
• Intravenous Valproate Inhibits Ongoing and Evoked Activity of Dura-sensitive Thalamic Neurons in Rats  
  Sokolov AY, Lyubashina OA, Sivachenko IB, Berkovich RR, Panteleev SS, Eur J Pharmacol, 1/31/2013
• Therapeutic Mechanisms of Action of Adrenocorticotropic Hormone (ACTH) And Other Melanocortin Peptides for the Clinical Management of Patients with MS  
  Arnason B, Berkovich R, Catania A. et al., Mult Scler, 1/1/2013
• Threatment of MS Exacerbations  
  Berkovich RR, Totolyan NA, Sokolov AY at al, Korsakoff Journal of Neurology and Psychiatry, 1/1/2013
• Natalizumab Reduces Apathy in Relapsing Remitting Multiple Sclerosis Patients  
  Berkovich R, European Neuropsychopharmacology, 1/1/2011
• Autoimmune Comorbid Conditions in Multiple Sclerosis  
  Berkovich R, Subhani D, Steinman L, US Neurology, 1/1/2011
• Natalizumab plus Interferon Beta-1a Reduces Lesion Formation in Relapsing Multiple Sclerosis  
  Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock..., J Neurol Sci, 1/1/2010
• The Impact of anti Anxiety Medication Mebicar on the Malone Dialdehyde Contents in Tissues and Blood Lipid Spectrum  
  Salikhova RR, The Journal of the European College of Neuropsychopharmacology, 1/1/2000
• The Impact of Tranquillizer Mebicar on the Lipid Metabolism on the Model Hypokinesia of Rats  
  Salikhova RR. Zimakova IE, Garaev RS, Experimental Biology and Medicine Journal, 1/1/1996
• Join now to see all

Books/Book Chapters

• See a Bigger Picture 
  Regina Berkovich, MD, PhD, MS Specialist2011

Abstracts/Posters

• Pilot Study of Monthly Pulse Adrenocorticotropic Hormone (ACTH) Or Methylprednisolone as an Add-on Therapy to Beta-interferons for Long-term Treatment of Multiple Scle...
  Berkovich R, Amezcua L, Subhani D, Cen S, American Academy of Neurology's 65th Annual Meeting, San Diego, CA, 1/16/2013
• Pilot Study of Monthly Pulse Adrenocorticotropic Hormone or Methylprednisolone as an Add-on Therapy to Beta-interferons for Long-term Treatment of Multiple Sclerosis
  Amezcua L, Axtell R, Cen S, Tauhid S; Neema M, Subhani D, Bakshi R, Steinman L and Berkovich R, 29th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, 1/2/2013
• Dynamics of the Peripheral Blood CD4 Cell Counts of JCV Ab Positive Patients at the Different Phases of Natalizumab Treatment
  Berkovich R, Togasaki D, Subhani D, Steinman L, ECTRIMS, Lyon, France, 1/12/2012
• Adrenocorticotropic Hormone Treatment of Multiple Sclerosis Exacerbations
  Berkovich R, Fernandez M, Subhani D, CMSC-ACTRIMS, 1/1/2012
• Investigator-Initiated Study: Pulse ACTH vs. MP
  Berkovich R, ECTRIMS, 1/1/2011
• Role of ACTH in MS
  Berkovich R, National MS Society Research Meeting, San Francisco, 1/1/2011
• DTI in Multiple Sclerosis Patients with and without Apathy
  Lerner A, Berkovich R, Law M, 48th Annual Meeting of the American Society for Neuroradiology, Boston, MA, 1/15/2010
• Expanded Laboratory Surveillance for PML in a Large Cohort of Patients on Natalizumab for Multiple Sclerosis
  Amezcua L, Berkovich R, Burnett M, Aparicio J, Kachuk N, 62nd Annual Meeting of the American Academy of Neurology, Toronto, Canada, 1/10/2010
• Apathy in Multiple Sclerosis and Its Association with Depression, Fatigue, and Cognitive Impairment
  Berkovich R, Spann B, 62nd Annual Meeting of the American Academy of Neurology, Toronto, Canada, 1/10/2010
• Four Cases of Co-morbid Multiple Sclerosis and Psoriasis: Sustained Remission of Both Conditions While on Natalizumab
  Berkovich R, 62nd Annual Meeting of the American Academy of Neurology, Toronto, Canada, 1/10/2010
• Monthly Pulse Adrenocorticotropin Hormone versus Methylprednisolone for Multiple Sclerosis Treatment
  Berkovich R, Gilmore W, Lund B, International Journal of MS Care, 1/1/2010
• IFN Beta1a Induced Changes in Myelin-specific T Cell Frequency May Serve as a Biomarker Predicting Clinical Outcome
  Amezcua L, Berkovich R, Tsao-Wei D, Bandari D, Kachuck NJ and Lund BT, The Twelfth Annual Meeting of Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), 1/2/2007
• The Use of Mebicar for Complex Therapy of Atherosclerosis
  Zimakova IE, Salikhova RR, Tagirova TS, Karpov AM, Methodological Recommendations, Kazan State Medical Academy, 1/1/1995
• Stress Protective and Hypolipidemic Effects of Mebicar
  Zimakova IE, Garaev RS, Salikhova RR, The Thesises of the 2nd Russian National Congress "Human Being and Medicine", Moscow, 1/1/1995
• The Impact of the Tranquillizers Mebicar and Seduxen on the Lipid Metabolism and Lipid Peroxydation
  Salikhova RR, The Thesis's of the Conference of Young Scientists, Kazan State Medical Academy, 1/1/1995
• The Use of Mebicar for Correction of Lipid Metabolism
  Tagirova TS, Zimakova IE, Salikhova RR, The Thesis's of the Republic Scientific Conference, 1/1/1994
• Hypolipidemic Effects of Mebicar
  Tagirova TS, Zimakova IE, Salikhova RR, Modern Problems of Psychiatry, Kazan, 1/1/1994
• The Use of Mebicar for Correction of Metabolism
  Dautova RK, Zimakova IE, Tagirova TS, Salikhova RR, Modern Problems of Psychiatry, Kazan, 1/1/1994
• Join now to see all

Lectures

• Clinical Experience with Aubagio [Launching of Aubagio in Russian Federation] 
  Yaroslavl, Russia - 1/24/2014
• Immunomodulatory Treatment Options for Multiple Sclerosis 
  Oregon - 1/17/2014
• Clinical Experience with Aubagio. [Launching of Aubagio in European Union] 
  Brussels, Belgium - 1/12/2014
• Changing Landscape of Treatments for Multiple Sclerosis 
  Phoenix, AZ - 1/6/2014
• Finding the Right DMT for the Right MS Patient 
  Ulyanovsk, Russia - 1/1/2013
• 21-year Long Term Follow-up of the Original Betaferon Pivotal Trial: Survival Data 
  Vienna, Austria - 1/1/2013
• Experience of Using Natalizumab (Tysabri) For Relapsing MS Patient 
  Kazan, Russia - 1/1/2013
• MS Management for the Primary Care Settings 
  Anaheim, California - 1/1/2013
• Updates on MS DMTs 
  St-Petersburg Pavlov State Medical University. St-Petersburg, Russia - 1/1/2013
• Clinical Cases Review 
  1/31/2012
• Role of ACTH in MS Treatment and Investigator Initiated Study 
  Kazan, Russia - 1/19/2012
• Currently Available Immunomodulatory Treatment Options for Multiple Sclerosis 
  USC Neurology - 1/19/2012
• Role of ACTH in MS Treatment 
  Lahey Clinic, Tufts University School of Medicine. Burlington, Massachusetts - 1/18/2012
• ACTH in MS Treatment 
  St-Petersburg Pavlov State Medical University, St-Petersburg, Russia - 1/17/2012
• Current DMTs for MS and Proposed Algorithm of Use 
  USC - 1/12/2012
• FDA-approved Treatments for Multiple Sclerosis 
  University of Nevada - 1/4/2012
• Natalizumab Reduces Apathy in Relapsing Remitting Multiple Sclerosis Patients 
  St-Petersburg - 1/1/2011
• Potential Role of ACTH for Long-term Treatment of MS 
  Harvard University - 1/1/2011
• MS and Autoimmune Comorbidities 
  Stanford Medical School - 1/1/2011
• Role of ACTH in MS 
  San Francisco - 1/1/2011
• New Approaches in Treatment of Advanced MS 
  Harbor UCLA - 1/1/2010
• Investigator-Initiated Trial 
  St.-Petersburg Pavlov State Medical University - 1/1/2010
• Updates to Multiple Sclerosis Treatment 
  St.-Petersburg Pavlov State Medical University - 1/1/2010
• Principally new MS medication for MS Natalizumab 
  1/1/2009
• Investigator-Initiated Study: Pulse ACTH vs. MP 
  Questcor, Chicago - 1/1/2009
• Join now to see all

Other

• Multiple Sclerosis: Treatment of Its Symptoms 
  Berkovich R, Kantor D, Reder AT, MedLink Neurology, MedLink Corporation
  http://www.medlink.com
  San Diego - 1/4/2013
• Immunomodulatory Agents in MS: Clinical Trials and Therapy 
  Berkovich R, Kantor D, Reder AT, MedLink Neurology, MedLink Corporation
  http://www.medlink.com
  San Diego - 1/10/2002